| Literature DB >> 33048973 |
Vincy Chan1, Mackenzie Hurst1, Tierza Petersen1, Jingqian Liu1, Tatyana Mollayeva1, Angela Colantonio1,2,3,4,5, Mitchell Sutton1, Michael D Escobar2.
Abstract
OBJECTIVE: To understand how pre-injury health status present five-years preceding traumatic brain injury (TBI) affects direct medical cost two years post-injury.Entities:
Mesh:
Year: 2020 PMID: 33048973 PMCID: PMC7553294 DOI: 10.1371/journal.pone.0240208
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Profile of patients in the emergency department or acute care for a TBI in Ontario, Canada, 2007/08–2013/14 (inclusive), by sample characteristics, sex, and location of first TBI healthcare encounter during the study period.
| Location of Encounter: Emergency Department N = 45,585 (81.9%) | Location of Encounter: Acute Care N = 10,084 (18.1%) | |||
|---|---|---|---|---|
| Male Patients N = 22,770 | Female Patients N = 22,815 | Male Patients N = 6,369 | Female Patients N = 3,715 | |
| Age | ||||
| Mean ± SD | 41.9 ± 18.3 | 44.8 ± 19.2 | 56.7 ± 20.6 | 64.7 ± 20.2 |
| Median (IQR) | 39.0 (26.0–54.0) | 43.0 (28.0–58.0) | 59.00 (40.0–74.0) | 69.00 (52.0–81.0) |
| Rural Residence (Yes) | 3,053 (13.4%) | 3,098 (13.6%) | 894 (14.0%) | 427 (11.5%) |
| Income Quintile | ||||
| 1 (Lowest) | 4,470 (19.6%) | 4,416 (19.4%) | 1,329 (20.9%) | 778 (20.9%) |
| 2 | 4,612 (20.3%) | 4,502 (19.7%) | 1,315 (20.7%) | 735 (19.8%) |
| 3 | 4,477 (19.7%) | 4,498 (19.7%) | 1,249 (19.6%) | 689 (18.6%) |
| 4 | 4,641 (20.3%) | 4,820 (21.1%) | 1,261 (19.8%) | 742 (19.9%) |
| 5 (Highest) | 4,570 (20.1%) | 4,579 (20.1%) | 1,215 (19.1%) | 771 (20.8%) |
| Injury Severity (AIS) | ||||
| Unspecified | 13,256 (58.2%) | 15,822 (69.4%) | 927 (14.6%) | 748 (20.1%) |
| Mild | 5,400 (23.7%) | 4,626 (20.3%) | 349 (5.5%) | 264 (7.1%) |
| Moderate | 1,404 (6.2%) | 611 (2.7%) | 303 (4.7%) | 215 (5.8%) |
| Severe | 2,710 (11.9%) | 1,756 (7.7%) | 4,790 (75.2%) | 2,488 (67.0%) |
| Mechanism of Injury | ||||
| Fall | 8,613 (37.8%) | 11,721 (51.4%) | 3,512 (55.1%) | 2,398 (64.6%) |
| Motor Vehicle Collision | 2,685 (11.8%) | 2,631 (11.5%) | 1,060 (16.6%) | 733 (19.7%) |
| Struck By/Against | 8,427 (37.0%) | 6,160 (27.0%) | 798 (12.5%) | 166 (4.5%) |
| Other | 3,033 (13.3%) | 2,297 (10.1%) | 992 (15.6%) | 408 (10.9%) |
| Unknown | 12 (0.05%) | 6 (0.03%) | 7 (0.1%) | 10 (0.3%) |
| Sports-Related Injury (Yes) | 4,904 (21.5%) | 3,180 (13.9%) | 512 (8.0%) | 190 (5.1%) |
| Fiscal Year of Discharge | ||||
| 2007/08 | 2,976 (13.1%) | 2,378 (10.4%) | 855 (13.4%) | 491 (13.2%) |
| 2008/09 | 2,842 (12.5%) | 2,573 (11.3%) | 842 (13.2%) | 425 (11.4%) |
| 2009/10 | 2,947 (12.9%) | 2,829 (12.4%) | 869 (13.6%) | 519 (14.0%) |
| 2010/11 | 3,114 (13.7%) | 2,967 (13.0%) | 888 (13.9%) | 508 (13.7%) |
| 2011/12 | 3,402 (14.9%) | 3,341 (14.6%) | 943 (14.8%) | 553 (14.9%) |
| 2012/13 | 3,545 (15.6%) | 3,853 (16.9%) | 972 (15.3%) | 603 (16.2%) |
| 2013/14 | 3,944 (17.3%) | 4,874 (21.4%) | 1,000 (15.7%) | 616 (16.6%) |
| LOS (Days) | ||||
| Mean ± SD | 9.8 ± 16.1 | 9.1 ± 14.0 | ||
| Median (IQR) | - | - | 5.0 (2.0–11.0) | 5.0 (2.0–11.0) |
| LOS (Hours) | ||||
| Mean ± SD | 4.9 ± 5.7 | 4.4 ± 5.8 | ||
| Median (IQR) | 3.4 (2.0–5.0) | 3.1 (1.8–4.9) | - | - |
| Special Care Days (Yes) | - | - | 2,601 (40.8%) | 1,224 (32.9%) |
| ALC Days | ||||
| Yes | 942 (14.8%) | 681 (18.3%) | ||
| Mean ± SD | - | - | 18.5 ± 37.3 | 16.5 ± 34.0 |
| Median (IQR) | 8.0 (4.0–19.0) | 7.0 (3.0–16.0) | ||
AIS: Abbreviated Injury Severity: ALC: Alternate Level of Care; IQR: Interquartile Range; LOS: Length of Stay; SD: Standard Deviation.
Total direct medical costs of publicly funded healthcare utilization, adjusted to the 2016 Canadian Dollar, within two years of emergency department or acute care discharge in Ontario, Canada, 2007/08–2013/14, by sex and location of first TBI encounter during the study period.
| Number of Unique Patients (Percent) | Cumulative Cost $CAD | Average Cost per Individual ± Standard Deviation | Median Cost per individual (Interquartile Range) | |
|---|---|---|---|---|
| All | 55,669 (100.0%) | $1,207,464,734 | $21,690 ± 56,077 | $4,446 ($1,634 - $14,675) |
| Location of First Healthcare Encounter | ||||
| Emergency Department | 45,585 (81.9%) | $563,301,851 | $12,357 ± $36,265 | $3,026 ($1,364 - $8,414) |
| Acute Care | 10,084 (18.1%) | $644,162,883 | $63,880 ± $96,134 | $26,779 ($12,361 - $78,222) |
| Fiscal Year of Discharge | ||||
| 2007/08 | 6,701 (12.0%) | $151,359,866 | $22,588 ± $55,308 | $4,623 ($1,643 - $15,981) |
| 2008/09 | 6,685 (12.0%) | $155,751,019 | $23,299 ± $58,927 | $4,772 ($1,677 - $15,734) |
| 2009/10 | 7,168 (12.9%) | $160,333,864 | $22,368 ± $56,366 | $4,965 ($1,687 - $16,176) |
| 2010/11 | 7,480 (13.4%) | $161,769,266 | $21,627 ± $53,944 | $4,561 ($1,676 - $14,975) |
| 2011/12 | 8,239 (14.8%) | $184,089,418 | $22,344 ± $60,377 | $4,602 ($1,605 - $14,745) |
| 2012/13 | 8,971 (16.1%) | $187,847,588 | $20,939 ± $55,624 | $4,227 ($1,600 - $13,822) |
| 2013/14 | 10,425 (18.7%) | $206,313,713 | $19,790 ± $52,709 | $3,983 ($1,602 - $12,481) |
| All | 29,139 (100.0%) | $682,664,415 | $23,428 ± $60,369 | $4,283 ($1,366 - $16,078) |
| Location of First Healthcare Encounter | ||||
| Emergency Department | 22,770 (78.1%) | $281,034,589 | $12,342 ± $37,613 | $2,492 ($1,095 - $7,864) |
| Acute Care | 6,369 (21.9%) | $401,629,826 | $63,060 ± $98,015 | $25,081 ($11,961 - $74,377) |
| Fiscal Year of Discharge | ||||
| 2007/08 | 3,831 (13.1%) | $89,142,829 | $23,269 ± $57,861 | $4,271 ($1,351 - $16,406) |
| 2008/09 | 3,684 (12.6%) | $88,333,040 | $23,977 ± $59,420 | $4,611 ($1,367 - $17,063) |
| 2009/10 | 3,817 (13.1%) | $91,872,478 | $24,069 ± $62,801 | $4,634 ($1,393 - $16,835) |
| 2010/11 | 4,004 (13.7%) | $91,006,117 | $22,729 ± $56,782 | $4,454 ($1,459 - $16,331) |
| 2011/12 | 4,346 (14.9%) | $105,017,395 | $24,164 ± $66,491 | $4,260 ($1,285 - $15,366) |
| 2012/13 | 4,517 (15.5%) | $104,991,274 | $23,244 ± $61,211 | $4,062 ($1,348 - $15,301) |
| 2013/14 | 4,940 (17.0%) | $112,301,282 | $22,733 ± $57,392 | $3,966 ($1,357 - $15,463) |
| All | 26,530 (100.0%) | $524,800,319 | $19,781 ± $50,881 | $4,578 ($1,914 - $13,249) |
| Location of First Healthcare Encounter | ||||
| Emergency Department | 22,815 (86.0%) | $282,267,262 | $12,372 ± $34,869 | $3,508 ($1,698 - $8,825) |
| Acute Care | 3,715 (14.0%) | $242,533,057 | $65,285 ± $92,818 | $30,277 ($13,260 - $82,619) |
| Fiscal Year of Discharge | ||||
| 2007/08 | 2,870 (10.8%) | $62,217,037 | $21,678 ± $51,702 | $4,911 ($1,986 - $15,497) |
| 2008/09 | 3,001 (11.3%) | $67,417,979 | $22,465 ± $58,316 | $4,947 ($1,994 - $14,383) |
| 2009/10 | 3,351 (12.6%) | $68,461,386 | $20,430 ± $47,931 | $5,260 ($1,990 - $15,364) |
| 2010/11 | 3,476 (13.1%) | $70,763,149 | $20,358 ± $50,456 | $4,606 ($1,953 - $13,898) |
| 2011/12 | 3,893 (14.7%) | $79,072,023 | $20,311 ± $52,654 | $4,749 ($1,944 - $14,098) |
| 2012/13 | 4,454 (16.8%) | $82,856,314 | $18,603 ± $49,214 | $4,315 ($1,834 - $12,575) |
| 2013/14 | 5,485 (20.7%) | $94,012,431 | $17,140 ± $47,952 | $3,994 ($1,794 - $10,729) |
Fig 1Bonferroni adjusted multivariable linear regression of pre-injury health status significantly associated with direct medical cost among patients in the emergency department for a TBI in Ontario, Canada, between 2007/08 and 2013/14, by sex.
Prevalence of pre-injury health status and multivariable linear regression models for direct medical cost among patients who first received TBI care in the emergency department.
| Male Patients | Female Patients | |||||||
|---|---|---|---|---|---|---|---|---|
| Factor Description | N (%) | Increase in Cost | Bonferroni Confidence Interval | p-value | N (%) | Increase in Cost | Bonferroni Confidence Interval | p-value |
| Factor 01: Cardiology—Cardiovascular disorders and other | 3,313 (14.6%) | 1.638 | (1.513–1.773) | <0.0001 | 3,860 (16.9%) | 1.632 | (1.528–1.744) | <0.0001 |
| Factor 02: Psychiatry—Mental health disorders; functional inquiry | 1,601 (7.0%) | 2.102 | (1.890–2.338) | <0.0001 | 1,972 (8.6%) | 1.933 | (1.771–2.108) | <0.0001 |
| Factor 03: Geriatrics—Disorders of elderly and medical issues | 2,625 (11.5%) | 1.787 | (1.640–1.948) | <0.0001 | 4,715 (20.7%) | 1.684 | (1.586–1.789) | <0.0001 |
| Factor 04: Trauma—Orthopedic injuries and other | 6,146 (27.0%) | 1.22 | (1.146–1.299) | <0.0001 | 5,408 (23.7%) | 1.379 | (1.302–1.461) | <0.0001 |
| Factor 05: Nephrology—Disorders of renal function and therapy | 160 (0.7%) | 4.701 | (3.384–6.531) | <0.0001 | 149 (0.7%) | 4.933 | (3.636–6.692) | <0.0001 |
| Factor 06: Dermatology osteopathy/orthopedy—Skin/soft tissue lesions, vascular/lymphatic pathology, back pain | 5,989 (26.3%) | 1.378 | (1.295–1.467) | <0.0001 | 6,603 (28.9%) | 1.483 | (1.405–1.566) | <0.0001 |
| Factor 07: Environmental exposures—Burns | 291 (1.3%) | 1.04 | (0.814–1.328) | 0.6031 | 273 (1.2%) | 1.315 | (1.049–1.649) | <0.0001 |
| Factor 08: Otolaryngology—Respiratory infections of upper airway, ear and nose | 3,189 (14.0%) | 1.214 | (1.121–1.315) | <0.0001 | 4,504 (19.7%) | 1.347 | (1.265–1.435) | <0.0001 |
| Factor 09: Gastroenterology—Liver disorders and other | 69 (0.3%) | 5.46 | (3.319–8.982) | <0.0001 | 48 (0.2%) | 3.916 | (2.291–6.692) | <0.0001 |
| Factor 10: Emergency medicine—Pulmonary, abdominal and other emergencies | 445 (2.0%) | 3.141 | (2.576–3.831) | <0.0001 | 738 (3.2%) | 2.346 | (2.042–2.694) | <0.0001 |
| Factor 11: Gastroenterology—Metabolic disorders and abdominal symptoms | 3,167 (13.9%) | 1.734 | (1.602–1.876) | <0.0001 | 5,503 (24.1%) | 1.771 | (1.674–1.874) | <0.0001 |
| Factor 12: Neurology—Stroke and emergencies involving the brain | 752 (3.3%) | 2.383 | (2.036–2.788) | <0.0001 | 884 (3.9%) | 2.149 | (1.886–2.448) | <0.0001 |
| Factor 13: Pharmacology emergencies—Adverse drug effects of prescribed medications | 142 (0.6%) | 3.574 | (2.526–5.057) | <0.0001 | 220 (1.0%) | 2.648 | (2.060–3.403) | <0.0001 |
| Factor 14: Toxicology—Emergencies and adversities due to substance abuse | 1,452 (6.4%) | 2.088 | (1.868–2.335) | <0.0001 | 1,044 (4.6%) | 1.99 | (1.769–2.237) | <0.0001 |
| Factor 15: Endocrinology—Diabetes and diabetic consequences | 931 (4.1%) | 2.343 | (2.035–2.698) | <0.0001 | 967 (4.2%) | 2.121 | (1.874–2.400) | <0.0001 |
| Factor 16: Gastroenterology and obstetrics—Conditions and symptoms of abdomen and pelvis | 2,842 (12.5%) | 1.506 | (1.387–1.635) | <0.0001 | 6,740 (29.5%) | 1.599 | (1.515–1.687) | <0.0001 |
| Factor 17: Cardiology—Chronic cardiovascular pathology | 519 (2.3%) | 2.674 | (2.219–3.223) | <0.0001 | 599 (2.6%) | 2.323 | (1.989–2.714) | <0.0001 |
| Factor 18: Trauma—Superficial injuries | 2,852 (12.5%) | 1.339 | (1.232–1.454) | <0.0001 | 3,098 (13.6%) | 1.44 | (1.340–1.547) | <0.0001 |
| Factor 19: Infectious diseases and respirology—Acute and chronic disorders of airway and lungs | 4,211 (18.5%) | 1.365 | (1.272–1.465) | <0.0001 | 5,679 (24.9%) | 1.395 | (1.318–1.476) | <0.0001 |
| Factor 20: Toxicology—Alcohol-related emergencies | 50 (0.2%) | 2.503 | (1.394–4.492) | <0.0001 | 44 (0.2%) | 2.978 | (1.701–5.215) | <0.0001 |
| Factor 21: Psychiatry—Schizophrenia and delusional disorders | 289 (1.3%) | 4.111 | (3.224–5.242) | <0.0001 | 275 (1.2%) | 3.457 | (2.763–4.325) | <0.0001 |
| Factor 22: Pharmacology emergencies—Poisoning due to narcotics | 161 (0.7%) | 3.341 | (2.411–4.629) | <0.0001 | 114 (0.5%) | 3.805 | (2.687–5.389) | <0.0001 |
| Factor 23: Trauma—Injuries from contact with sharp instruments and machinery | 3,491 (15.3%) | 1.18 | (1.093–1.274) | <0.0001 | 1,941 (8.5%) | 1.237 | (1.132–1.352) | <0.0001 |
| Factor 24: Pharmacology emergencies—Poisoning due to hormones, cardiovascular drugs and other | 94 (0.4%) | 2.842 | (1.855–4.355) | <0.0001 | 181 (0.8%) | 2.817 | (2.137–3.714) | <0.0001 |
| Factor 25: Pharmacology emergencies—Poisoning by pain killers and anti-inflammatory drugs | 70 (0.3%) | 1.904 | (1.161–3.123) | <0.0001 | 139 (0.6%) | 2.689 | (1.961–3.688) | <0.0001 |
| Factor 26: Neurology—Epilepsy, seizures, brain lesions and other | 233 (1.0%) | 2.816 | (2.147–3.695) | <0.0001 | 238 (1.0%) | 2.686 | (2.110–3.418) | <0.0001 |
| Factor 27: Trauma—Overexertion and injuries to the lower limb | 3,784 (16.6%) | 1.201 | (1.115–1.294) | <0.0001 | 3,612 (15.8%) | 1.327 | (1.240–1.420) | <0.0001 |
| Factor 28: Nephrology—Genitourinary disorders, disorders of prostate, other | 1,098 (4.8%) | 1.66 | (1.459–1.889) | <0.0001 | 2,673 (11.7%) | 1.571 | (1.456–1.695) | <0.0001 |
| Factor 29: Neurology—Alzheimer’s diseases and dementia | 39 (0.2%) | 4.481 | (2.306–8.707) | <0.0001 | 71 (0.3%) | 5.014 | (3.220–7.808) | <0.0001 |
| Factor 30: Emergency medicine—Foreign body in eye, airway and other | 647 (2.8%) | 1.072 | (0.909–1.265) | 0.1692 | 282 (1.2%) | 1.25 | (1.001–1.562) | 0.0011 |
| Factor 31: Emergency medicine—Complications of medical procedures | 698 (3.1%) | 2.037 | (1.738–2.388) | <0.0001 | 892 (3.9%) | 1.766 | (1.556–2.004) | <0.0001 |
| Factor 32: Environmental exposures—Exposure to heat and light | 16 (0.1%) | 1.206 | (0.429–3.391) | 0.5561 | 9 (0.04%) | 1.315 | (0.381–4.539) | 0.4722 |
| Factor 33: Environmental exposures—Exposure to cold/hypothermia | 22 (0.1%) | 2.838 | (1.176–6.853) | 0.0001 | 10 (0.04%) | 0.79 | (0.244–2.559) | 0.5154 |
| Factor 34: Environmental exposures—Bee, wasp and hornet stings | 115 (0.5%) | 1.228 | (0.834–1.808) | 0.0842 | 125 (0.6%) | 1.248 | (0.894–1.742) | 0.0308 |
| Factor 35: Infectious diseases—Viral conjunctivitis | 17 (0.1%) | 0.747 | (0.274–2.038) | 0.3459 | 27 (0.1%) | 1.13 | (0.553–2.311) | 0.5793 |
| Factor 36: Trauma—Assault and intentional injury | 511 (2.2%) | 1.465 | (1.218–1.763) | <0.0001 | 209 (0.9%) | 1.533 | (1.185–1.985) | <0.0001 |
| Factor 37: Pharmacology emergencies—Adverse reactions to antibiotics and other drugs | 940 (4.1%) | 1.305 | (1.137–1.498) | <0.0001 | 1,412 (6.2%) | 1.471 | (1.328–1.628) | <0.0001 |
| Factor 38: Trauma—Adult and child abuse and sexual assault | 7 (0.03%) | 1.352 | (0.283–6.451) | 0.5309 | 75 (0.3%) | 1.991 | (1.296–3.060) | <0.0001 |
| Factor 39: Environmental exposures—Burn and chemical poisoning | 191 (0.8%) | 1.225 | (0.907–1.655) | 0.0282 | 173 (0.8%) | 1.602 | (1.207–2.127) | <0.0001 |
| Factor 40: Gynecology—Infections of reproductory organs and other | 53 (0.2%) | 1.269 | (0.719–2.241) | 0.1733 | 355 (1.6%) | 1.631 | (1.336–1.990) | <0.0001 |
| Factor 41: Pharmacology emergencies—Poisoning due to drugs acting on autonomic nervous system | < 6 | 3.349 | (0.527–21.268) | 0.0337 | 12 (0.1%) | 1.001 | (0.343–2.927) | 0.9967 |
| Factor 42: Environmental exposures—Toxic effect of gases, fumes and vapors | 72 (0.3%) | 1.051 | (0.645–1.713) | 0.7394 | 53 (0.2%) | 1.662 | (0.997–2.770) | 0.0012 |
| Factor 43: Environmental exposures—Exposure to electrical current | 32 (0.1%) | 0.977 | (0.470–2.031) | 0.9189 | 18 (0.08%) | 1.147 | (0.478–2.754) | 0.6108 |
Notes: * indicates statistically significant after Bonferroni Adjustment.
Fig 2Bonferroni adjusted multivariable linear regression of pre-injury health status significantly associated with direct medical cost among patients in the acute care for a TBI in Ontario, Canada, between 2007/08 and 2013/14, by sex.
Prevalence of pre-injury health status and multivariable linear regression models for direct medical cost among patients who first received TBI care in the acute care setting.
| Male Patients | Female Patients | |||||||
|---|---|---|---|---|---|---|---|---|
| Factor Description | N (%) | Increase in Cost | Bonferroni Confidence Interval | p-value | N (%) | Increase in Cost | Bonferroni Confidence Interval | p-value |
| Factor 01: Cardiology—Cardiovascular disorders and other | 1,542 (24.2%) | 1.316 | (1.172–1.478) | <0.0001 | 1,030 (27.7%) | 1.292 | (1.127–1.482) | <0.0001 |
| Factor 02: Psychiatry—Mental health disorders; functional inquiry | 362 (5.7%) | 1.386 | (1.130–1.698) | <0.0001 | 249 (6.7%) | 1.402 | (1.109–1.771) | <0.0001 |
| Factor 03: Geriatrics—Disorders of elderly and medical issues | 1,277 (20.1%) | 1.417 | (1.254–1.601) | <0.0001 | 1,147 (30.9%) | 1.338 | (1.174–1.526) | <0.0001 |
| Factor 04: Trauma—Orthopedic injuries and other | 905 (14.2%) | 1.134 | (0.991–1.299) | 0.0025 | 572 (15.4%) | 1.172 | (0.997–1.378) | 0.0014 |
| Factor 05: Nephrology—Disorders of renal function and therapy | 210 (3.3%) | 1.816 | (1.394–2.365) | <0.0001 | 131 (3.5%) | 2.021 | (1.473–2.773) | <0.0001 |
| Factor 06: Dermatology osteopathy/orthopedy—Skin/soft tissue lesions, vascular/lymphatic pathology, back pain | 1,366 (21.5%) | 1.133 | (1.010–1.270) | 0.0004 | 822 (22.1%) | 1.147 | (0.996–1.322) | 0.0016 |
| Factor 07: Environmental exposures—Burns | 40 (0.6%) | 1.19 | (0.658–2.154) | 0.3408 | 14 (0.4%) | 0.974 | (0.375–2.530) | 0.9277 |
| Factor 08: Otolaryngology—Respiratory infections of upper airway, ear and nose | 454 (7.1%) | 1.107 | (0.921–1.329) | 0.0725 | 315 (8.5%) | 1.155 | (0.934–1.427) | 0.0273 |
| Factor 09: Gastroenterology—Liver disorders and other | 73 (1.2%) | 1.285 | (0.827–1.996) | 0.0643 | 44 (1.2%) | 1.322 | (0.770–2.270) | 0.0936 |
| Factor 10: Emergency medicine—Pulmonary, abdominal and other emergencies | 551 (8.7%) | 1.642 | (1.385–1.945) | <0.0001 | 471 (12.7%) | 1.658 | (1.387–1.981) | <0.0001 |
| Factor 11: Gastroenterology—Metabolic disorders and abdominal symptoms | 1,549 (24.3%) | 1.233 | (1.100–1.382) | <0.0001 | 1,173 (31.8%) | 1.23 | (1.081–1.400) | <0.0001 |
| Factor 12: Neurology—Stroke and emergencies involving the brain | 865 (13.6%) | 1.411 | (1.223–1.629) | <0.0001 | 678 (18.3%) | 1.398 | (1.193–1.637) | <0.0001 |
| Factor 13: Pharmacology emergencies—Adverse drug effects of prescribed medications | 43 (0.7%) | 2.122 | (1.197–3.761) | <0.0001 | 34 (0.9%) | 1.817 | (0.982–3.360) | 0.0016 |
| Factor 14: Toxicology—Emergencies and adversities due to substance abuse | 380 (6.0%) | 1.35 | (1.106–1.647) | <0.0001 | 137 (3.7%) | 1.32 | (0.966–1.804) | 0.0039 |
| Factor 15: Endocrinology—Diabetes and diabetic consequences | 659 (10.4%) | 1.316 | (1.123–1.541) | <0.0001 | 395 (10.6%) | 1.3 | (1.072–1.575) | <0.0001 |
| Factor 16: Gastroenterology and obstetrics—Conditions and symptoms of abdomen and pelvis | 688 (10.8%) | 1.172 | (1.008–1.364) | 0.0007 | 825 (22.2%) | 1.257 | (1.092–1.446) | <0.0001 |
| Factor 17: Cardiology—Chronic cardiovascular pathology | 487 (7.7%) | 1.444 | (1.205–1.731) | <0.0001 | 373 (10.0%) | 1.378 | (1.130–1.681) | <0.0001 |
| Factor 18: Trauma—Superficial injuries | 450 (7.1%) | 1.035 | (0.861–1.243) | 0.5438 | 296 (8.0%) | 1.201 | (0.967–1.490) | 0.006 |
| Factor 19: Infectious diseases and respirology—Acute and chronic disorders of airway and lungs | 921 (14.5%) | 1.227 | (1.073–1.403) | <0.0001 | 628 (16.9%) | 1.184 | (1.013–1.385) | 0.0004 |
| Factor 20: Toxicology—Alcohol-related emergencies | 15 (0.2%) | 1.701 | (0.647–4.474) | 0.0743 | 8 (0.2%) | 1.806 | (0.511–6.379) | 0.1282 |
| Factor 21: Psychiatry—Schizophrenia and delusional disorders | 89 (1.4%) | 1.525 | (1.022–2.275) | 0.0006 | 61 (1.6%) | 2.045 | (1.289–3.244) | <0.0001 |
| Factor 22: Pharmacology emergencies—Poisoning due to narcotics | 40 (0.6%) | 1.87 | (1.032–3.387) | 0.0006 | 17 (0.5%) | 1.577 | (0.663–3.752) | 0.0879 |
| Factor 23: Trauma—Injuries from contact with sharp instruments and machinery | 593 (9.3%) | 1.111 | (0.944–1.307) | 0.0362 | 181 (4.9%) | 0.97 | (0.739–1.275) | 0.7199 |
| Factor 24: Pharmacology emergencies—Poisoning due to hormones, cardiovascular drugs and other | 38 (0.6%) | 1.84 | (1.002–3.379) | 0.0011 | 20 (0.5%) | 1.668 | (0.751–3.708) | 0.0374 |
| Factor 25: Pharmacology emergencies—Poisoning by pain killers and anti-inflammatory drugs | 11 (0.2%) | 1.613 | (0.522–4.990) | 0.1688 | 13 (0.4%) | 2.123 | (0.787–5.726) | 0.0137 |
| Factor 26: Neurology—Epilepsy, seizures, brain lesions and other | 145 (2.3%) | 1.584 | (1.158–2.168) | <0.0001 | 79 (2.1%) | 1.684 | (1.123–2.524) | <0.0001 |
| Factor 27: Trauma—Overexertion and injuries to the lower limb | 496 (7.8%) | 1.004 | (0.841–1.199) | 0.9391 | 278 (7.5%) | 1.065 | (0.852–1.331) | 0.3604 |
| Factor 28: Nephrology—Genitourinary disorders, disorders of prostate, other | 673 (10.6%) | 1.303 | (1.114–1.523) | <0.0001 | 619 (16.7%) | 1.307 | (1.117–1.530) | <0.0001 |
| Factor 29: Neurology—Alzheimer’s diseases and dementia | 54 (0.9%) | 2.351 | (1.408–3.927) | <0.0001 | 83 (2.2%) | 2.057 | (1.382–3.061) | <0.0001 |
| Factor 30: Emergency medicine—Foreign body in eye, airway and other | 114 (1.8%) | 1.158 | (0.814–1.650) | 0.1766 | 28 (0.8%) | 1.033 | (0.525–2.034) | 0.8747 |
| Factor 31: Emergency medicine—Complications of medical procedures | 443 (7.0%) | 1.359 | (1.128–1.638) | <0.0001 | 272 (7.3%) | 1.255 | (1.002–1.572) | 0.0011 |
| Factor 32: Environmental exposures—Exposure to heat and light | < 6 | 3.707 | (0.571–24.069) | 0.0229 | - | |||
| Factor 33: Environmental exposures—Exposure to cold/hypothermia | < 6 | 1.07 | (0.123–9.284) | 0.9193 | < 6 | 0.78 | (0.022–27.667) | 0.8215 |
| Factor 34: Environmental exposures—Bee, wasp and hornet stings | 24 (0.4%) | 0.648 | (0.301–1.391) | 0.0649 | 9 (0.2%) | 0.902 | (0.275–2.961) | 0.7773 |
| Factor 35: Infectious diseases—Viral conjunctivitis | < 6 | 0.265 | (0.019–3.735) | 0.1032 | < 6 | 0.725 | (0.092–5.693) | 0.6121 |
| Factor 36: Trauma—Assault and intentional injury | 78 (1.2%) | 1.16 | (0.757–1.777) | 0.2593 | 33 (0.9%) | 0.958 | (0.514–1.787) | 0.824 |
| Factor 37: Pharmacology emergencies—Adverse reactions to antibiotics and other drugs | 155 (2.4%) | 1.054 | (0.777–1.429) | 0.575 | 103 (2.8%) | 1.298 | (0.909–1.854) | 0.0174 |
| Factor 38: Trauma—Adult and child abuse and sexual assault | - | < 6 | 0.913 | (0.185–4.502) | 0.8526 | |||
| Factor 39: Environmental exposures—Burn and chemical poisoning | 28 (0.4%) | 1.207 | (0.594–2.451) | 0.389 | 8 (0.2%) | 1.739 | (0.492–6.150) | 0.1545 |
| Factor 40: Gynecology—Infections of reproductory organs and other | 14 (0.2%) | 1.005 | (0.369–2.734) | 0.9868 | 26 (0.7%) | 1.638 | (0.813–3.301) | 0.0223 |
| Factor 41: Pharmacology emergencies—Poisoning due to drugs acting on autonomic nervous system | < 6 | 3.121 | (0.360–27.066) | 0.087 | < 6 | 2.905 | (0.590–14.311) | 0.0299 |
| Factor 42: Environmental exposures—Toxic effect of gases, fumes and vapors | 14 (0.2%) | 0.887 | (0.326–2.414) | 0.6969 | < 6 | 1.043 | (0.084–12.981) | 0.9564 |
| Factor 43: Environmental exposures—Exposure to electrical current | < 6 | 1.077 | (0.124–9.339) | 0.9113 | < 6 | 0.463 | (0.037–5.766) | 0.3214 |
Notes: * indicates statistically significant after Bonferroni Adjustment.